Cite
HARVARD Citation
van Oers, M. et al. (2015). Ofatumumab maintenance versus observation in relapsed chronic lymphocytic leukaemia (PROLONG): an open-label, multicentre, randomised phase 3 study. Lancet oncology. 16 (13), pp. 1370-1379. [Online].